Literature DB >> 30454954

CRISPR/Cas9 and p53: An Odd Couple Requiring Relationship Management.

Seppo Ylä-Herttuala1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30454954      PMCID： PMC6277499          DOI： 10.1016/j.ymthe.2018.11.001

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  4 in total

1.  DNA repair processes are critical mediators of p53-dependent tumor suppression.

Authors:  Ana Janic; Liz J Valente; Matthew J Wakefield; Leon Di Stefano; Liz Milla; Stephen Wilcox; Haoyu Yang; Lin Tai; Cassandra J Vandenberg; Andrew J Kueh; Shinsuke Mizutani; Margs S Brennan; Robyn L Schenk; Lisa M Lindqvist; Anthony T Papenfuss; Liam O'Connor; Andreas Strasser; Marco J Herold
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

2.  p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.

Authors:  Robert J Ihry; Kathleen A Worringer; Max R Salick; Elizabeth Frias; Daniel Ho; Kraig Theriault; Sravya Kommineni; Julie Chen; Marie Sondey; Chaoyang Ye; Ranjit Randhawa; Tripti Kulkarni; Zinger Yang; Gregory McAllister; Carsten Russ; John Reece-Hoyes; William Forrester; Gregory R Hoffman; Ricardo Dolmetsch; Ajamete Kaykas
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

3.  CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.

Authors:  Emma Haapaniemi; Sandeep Botla; Jenna Persson; Bernhard Schmierer; Jussi Taipale
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

4.  In vivo CRISPR editing with no detectable genome-wide off-target mutations.

Authors:  Pinar Akcakaya; Maggie L Bobbin; Jimmy A Guo; Jose Malagon-Lopez; Kendell Clement; Sara P Garcia; Mick D Fellows; Michelle J Porritt; Mike A Firth; Alba Carreras; Tania Baccega; Frank Seeliger; Mikael Bjursell; Shengdar Q Tsai; Nhu T Nguyen; Roberto Nitsch; Lorenz M Mayr; Luca Pinello; Mohammad Bohlooly-Y; Martin J Aryee; Marcello Maresca; J Keith Joung
Journal:  Nature       Date:  2018-09-12       Impact factor: 49.962
  4 in total
  2 in total

Review 1.  CRISPR-based genome editing through the lens of DNA repair.

Authors:  Tarun S Nambiar; Lou Baudrier; Pierre Billon; Alberto Ciccia
Journal:  Mol Cell       Date:  2022-01-20       Impact factor: 17.970

2.  Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency.

Authors:  Yu-Shui Ma; Xiao-Feng Wang; Yun-Jie Zhang; Pei Luo; Hui-Deng Long; Liu Li; Hui-Qiong Yang; Ru-Ting Xie; Cheng-You Jia; Gai-Xia Lu; Zheng-Yan Chang; Jia-Jia Zhang; Shao-Bo Xue; Zhong-Wei Lv; Fei Yu; Qing Xia; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2020-01-11       Impact factor: 7.200
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.